Duration of antibody responses after severe acute respiratory syndrome

被引：294

作者：

Wu, Li-Ping

Wang, Nai-Chang

Chang, Yi-Hua

Tian, Xiang-Yi

Na, Dan-Yu

Zhang, Li-Yuan

Zheng, Lei

Lan, Tao

Wang, Lin-Fa

Liang, Guo-Dong ^{[1
]}

机构：

[1] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China

[2] Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China

[3] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia

[4] Australian Biosecurity Ctr Emerging Infect Dis, Geelong, Vic, Australia

[5] State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 10期

关键词：

D O I：

10.3201/eid1310.070576

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.

引用

页码：1562 / 1564

页数：3

共 50 条

[31] Severe acute respiratory syndrome
Christian, MD
Poutanen, SM
Loutfy, MR
Muller, MP
Low, DE
CLINICAL INFECTIOUS DISEASES, 2004, 38 (10) : 1420 - 1427
[32] Severe acute respiratory syndrome
Chan-Yeung, M
Ooi, GC
Hui, DS
Ho, PL
Tsang, KW
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (12) : 1117 - 1130
[33] Fibromyalgia after severe acute respiratory syndrome: a case report
TIAN Xinping ZENG Xiaofeng and XU WenbinDepartment of Rheumatology Department of Respiratory Disease Peking Union Medical College Hospital Peking Union Medical College Chinese Academy of Medical Sciences Beijing China
ChineseMedicalJournal, 2006, (10) : 875 - 877
[34] Fibromyalgia after severe acute respiratory syndrome: a case report
Tian, XP
Zeng, XF
Xu, WB
CHINESE MEDICAL JOURNAL, 2006, 119 (10) : 875 - 877
[35] Fibromyalgia after severe acute respiratory syndrome: a case report
TIAN Xin-ping
中华医学杂志(英文版), 2006, (10) : 875 - 877
[36] Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers
Tan, YJ
Goh, PY
Fielding, BC
Shen, S
Chou, CF
Fu, JL
Leong, HN
Leo, YS
Ooi, EE
Ling, AE
Lim, SG
Hong, WJ
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (02) : 362 - 371
[37] Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity
Lynch, Kara L.
Whitman, Jeffrey D.
Lacanienta, Noreen P.
Beckerdite, Erica W.
Kastner, Shannon A.
Shy, Brian R.
Goldgof, Gregory M.
Levine, Andrew G.
Bapat, Sagar P.
Stramer, Susan L.
Esensten, Jonathan H.
Hightower, Allen W.
Bern, Caryn
Wu, Alan H. B.
CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 301 - 308
[38] Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients
Wang, Xiaoli
Guo, Xianghua
Xin, Qianqian
Pan, Yang
Hu, Yaling
Li, Jing
Chu, Yanhui
Feng, Yingmei
Wang, Quanyi
CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2688 - 2694
[39] Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Testing: Important but Imperfect
Stapleton, Jack T.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E3074 - E3076
[40] Acute Myocarditis After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
LaJoie, Joan
Lentz, Brian
JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (02):

← 1 2 3 4 5 →